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MAP kinase pathway. The selective inhibitor of PKG, KT5823, 
prevented the proliferative effect induced by NO at 24 h but 
not at 6 h. In conclusion, the proliferative effect of NO is ini-
tially mediated by the ERK/MAPK pathway, and at later stag-
es by the GC/cGMP/PKG pathway. Thus, our work shows that 
NO induces neural stem cell proliferation by targeting these 
two pathways in a biphasic manner. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 An injury to the central nervous system often results 
in neuroinflammation, which is characterized by the 
activation of resident microglial cells, astrocytes, and 
eventually by infiltrating peripheral macrophages and 
lymphocytes, recently reviewed by Whitney et al.  [1] . It 
is now well established that inflammation affects the 
formation of new cells following brain injury  [2–4] . An 
acute brain insult, such as stroke, seizures, or trauma, 
often elicits a proliferative response from the neurogen-
ic niches  [5–9] . New cells are attracted to the lesioned 
areas in order to replace the lost neural cells  [10] . Factors 
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 Abstract 
 Nitric oxide (NO) is an important inflammatory mediator in-
volved in the initial boost in the proliferation of neural stem 
cells following brain injury. However, the mechanisms un-
derlying the proliferative effect of NO are still unclear. The 
aim of this work was to investigate whether cyclic GMP 
(cGMP) and the cGMP-dependent kinase (PKG) are involved 
in the proliferative effect triggered by NO in neural stem 
cells. For this purpose, cultures of neural stem cells isolated 
from the mouse subventricular zone (SVZ) were used. We
observed that long-term exposure to the NO donor (24 h), 
NOC-18, increased the proliferation of SVZ cells in a cGMP-
dependent manner, since the guanylate cyclase inhibitor, 
ODQ, prevented cell proliferation. Similarly to NOC-18, the 
cGMP analogue, 8-Br-cGMP, also increased cell proliferation. 
Interestingly, shorter exposures to NO (6 h) increased cell 
proliferation in a cGMP-independent manner via the ERK/
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produced and released by immune cells during the neu-
roinflammatory response affect the proliferation, mi-
gration, and differentiation of neuronal precursors fol-
lowing a lesion  [11, 12] . Microglial cells can produce a 
wide range of pro- and anti-inflammatory mediators, 
which can differentially affect the different steps of neu-
rogenesis  [2, 3, 13] . Among such factors, nitric oxide 
(NO) is of particular interest given its notable features 
such as short half-life, diffusivity, and signaling proper-
ties  [1] .
 NO is a free radical produced by NO synthases and a 
pleiotropic messenger in several biological processes  [14] . 
Recent studies have shown the involvement of NO on 
neurogenesis, either in basal conditions or following an 
injury. Particularly, NO was described as a physiological 
inhibitor of neurogenesis in mice  [15–18] . Other studies 
demonstrated that NO is important for the initial in-
crease in proliferation of neural stem cells in the neuro-
genic niches following stroke  [19] or seizures  [20] . We re-
cently showed that the NO donor 2,2  -(hydroxynitro-
sohydrazino)bis-ethanamine (NOC-18) can stimulate 
proliferation of isolated neural stem cells in culture when 
used in low doses (1–10   M )  [20] . Nevertheless, the mech-
anisms underlying the proliferative effect of NO are not 
yet identified.
 The main biological target of NO is the heme-con-
taining enzyme guanylyl cyclase. Guanylyl cyclase cata-
lyzes the conversion of GTP to cyclic GMP (cGMP), 
which in turn can act on further downstream targets 
such as the cGMP-dependent kinase (PKG) and cGMP-
gated channels. In a variety of cell types, NO and cGMP 
have been described as important effectors in several
cellular processes, including survival, differentiation, 
growth, axon guidance or migration, through the activa-
tion of different downstream signaling cascades  [21–23] . 
Neurogenesis is positively affected by cGMP and cGMP-
sparing agents such as sildenafil or tadalafil  [21, 24–26] . 
However, it remains to be established whether cGMP 
and PKG are responsible for the proliferative effect of NO 
when applied to neural stem cells. Within this scenario, 
we investigated the role of the guanylyl cyclase-cGMP-
PKG pathway in the proliferative effect of NO. We ob-
served that cGMP analogues mimic the effect of NO in 
increasing cell proliferation. Moreover, blocking guany-
lyl cyclase or PKG prevented the proliferative effect of 
NO, thus pointing to the involvement of the NO-cGMP 
signaling pathway in the enhancement of neural stem 
cell proliferation.
 Materials and Methods 
 Materials 
 Dulbecco’s modified Eagle’s medium:F-12 nutrient mixture 
(D-MEM/F-12, with GlutaMAX TM -I), B27 supplement, trypsin-
EDTA solution (0.05% trypsin, 1 m M EDTA in Hanks balanced 
salt solution, antibiotic (10,000 units/ml penicillin, 10 mg/ml 
streptomycin), epidermal growth factor, basic fibroblast growth 
factor and Click-iT  EdU Alexa Fluor  488 Flow Cytometry As-
say Kit were purchased from Invitrogen (Paisley, UK). 5-Bromo-
2  -deoxyuridine (BrdU), 8-bromoguanosine 3  ,5  -cyclic mono-
phosphate (8-Br-cGMP), phenylmethylsufonyl fluoride, dithio-
threitol, orthovanadate, chymostatin, leuptin, antiparin, pepstatin 
A, trypan blue and 1,4-diamino-2,3-dicyano-1,4-bis( o -amino-
phenylmercapto)butadiene monoethanolate (U0126) were pur-
chased from Sigma Chemical (St. Louis, Mo., USA). KT5823 was 
purchased from Alomone Labs (Jerusalem, Israel). 1H-[1,2,4]
oxadiozolo[4,3-a]quinoxalin-1-one (ODQ) and zaprinast were 
obtained from Tocris Bioscience (Bristol, UK). Mouse anti-Sox-2 
was purchased from R&D Systems (Minneapolis, Minn., USA) 
and rabbit anti-nestin from Santa Cruz Biotechnology (Santa 
Cruz, Calif., USA). NOC-18 was obtained from Alexis Biochemi-
cals (San Diego, Calif., USA). A DAKO fluorescence mounting 
medium was purchased from DakoCytomation (Glostrup, Den-
mark). Rat anti-mouse BrdU was obtained from Oxford Biotech-
nology (Oxford, UK). Hoechst 33342 dye, anti-rat IgG conjugated 
with Alexa Fluor 594, anti-mouse IgG conjugated with Alexa
Fluor 594 and anti-rabbit IgG conjugated with Alexa Fluor 488 
secondary antibodies were purchased from Molecular Probes 
(Leiden, The Netherlands). Polyvinylidene difluoride mem-
branes, enhanced chemifluorescence reagent, cGMP BioTRAK, 
alkaline phosphatase-linked anti-rabbit and anti-mouse second-
ary antibodies were obtained from Amersham Pharmacia Biotech 
(Little Chalfont, UK). Monoclonal mouse anti-p44/42 MAPK 
(ERK1/2) and rabbit anti-phospho-ERK1/2 antibodies were ob-
tained from Cell Signaling Technology (Danvers, Mass., USA). 
Other reagents used in immunoblotting experiments were pur-
chased from BioRad (Hercules, Calif., USA).
 Animals 
 C57BL/6J mice were obtained from Charles River (Barcelona, 
Spain) and kept with food and water ad libitum in a 12-hour 
dark:light cycle. All experiments were performed in accordance 
with the NIH and the European (86/609/EEC) guidelines for the 
care and use of laboratory animals. 
 Subventricular Zone Neural Stem Cell Cultures 
 Neural stem cell cultures were obtained from the subventricular 
zone (SVZ) of postnatal day 0–3 C57BL/6J mice, as previously de-
scribed  [20] . Briefly, the brains were removed from the skull follow-
ing decapitation, and placed in a dissection medium composed of 
Ca 2+ - and Mg 2+ -free Hanks balanced salt solution (137 m M NaCl, 
5.36 m M KCl, 0.44 m M KH 2 PO 4 , 0.34 m M Na 2 PO 4  2H 2 O, 4.16 m M 
NaHCO 3 , 5 m M glucose, 1 m M sodium pyruvate, 10 m M HEPES, 
pH 7.4), supplemented with 0.25% gentamicin. After removing the 
enveloping meninges, the cerebellum was discarded and the whole 
cortex tissue was cut in 450-  m-thick coronal sections using a 
MclLwain tissue chopper (The Mickle Laboratory Engineering Co. 
Ltd., Guildford, UK). The fragments of SVZ encompassing both 
ependymal and subependymal layers were digested in 0.025% tryp-
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sin and 0.265 m M EDTA for 20 min at 37   °   C, and dissociated by 
gentle trituration with a pipette tip. Following dissociation, the 
cells were resuspended in fresh D-MEM/F-12 with GlutaMAX-I, 
supplemented with 1% B27, 1% antibiotic (10,000 units/ml penicil-
lin, 10 mg/ml streptomycin), 10 ng/ml epidermal growth factor and 
10 ng/ml basic fibroblast growth factor. Cells were then plated on 
uncoated Petri dishes at a density of 3,000 cells/cm 2 . The SVZ stem 
cells were grown as floating neurospheres in a 95% air/5% CO 2 hu-
midified atmosphere at 37  °  C. Seven days following plating, the pri-
mary neurospheres were harvested, centrifuged and dissociated as 
single cells. Cells were then replated as above and allowed to grow 
as secondary neurospheres. Neurospheres with 2–4 passages were 
collected and plated for 5 days on glass coverslips, 16 mm in diam-
eter,  for immunocytochemistry assays, or on 12-well plates, coated 
with poly- L -lysine, in a serum-free medium, without growth fac-
tors, for preparation of lysates or flow cytometry assays.
 Characterization of SVZ Primary Cultures 
 SVZ-derived neural stem cells plated on poly- L -lysine-coated 
coverslips for 5 days (in a minimum of 3 independent experi-
ments) were fixed with 4% paraformaldehyde/4% sucrose in phos-
phate-buffered saline (PBS, 0.1  M ). The cells were then permeabi-
lized with 1% Triton X-100 for 5 min. Nonspecific binding was 
blocked with 3% BSA in 0.2% Tween 20 in PBS (PBS-T) for 1 h, 
and cells were labeled with the primary antibodies mouse anti-
Sox-2 (1: 100) and rabbit anti-nestin (1: 100) for 90 min at room 
temperature. The cells were then exposed to secondary antibodies 
anti-mouse and anti-rabbit IgGs conjugated with Alexa Fluor 594 
and 488 (1: 200), respectively, for 1 h at room temperature. Nuclei 
were stained with Hoechst 33342 (1   g/ml) for 3 min. Coverslips 
were mounted on glass slides using a DAKO fluorescence mount-
ing medium. Images were acquired in a laser scanning micro-
scope LSM 510 META (Zeiss, Jena, Germany).
 Experimental Treatments in SVZ Cell Cultures  
 SVZ-derived neural stem cells were exposed to the NO donor 
NOC-18 (10   M ) or to the cGMP analogue 8-Br-cGMP (20   M ) 
for different periods of time, as indicated in detail in the figure 
legends and in the text. The guanylyl cyclase inhibitor ODQ (50 
  M ), the protein kinase G (PKG) inhibitor KT5823 (1   M ) and the 
MEK1/2 inhibitor U0126 (1   M ) were added 30 min before NOC-
18 or 8-Br-cGMP and kept throughout the incubation period.
 Decomposed NOC-18 was prepared by diluting a 10 m M NOC-
18 stock solution (prepared in 0.01  M NaOH, which keeps NOC-18 
from releasing NO in alkaline solutions) to 1 m M NOC-18 in a 
culture medium (pH 7.0, since NOC-18 releases NO at this pH), 
which was kept for 72 h at room temperature on a lab bench, un-
protected from light. This solution was used to treat SVZ cultures 
in a final concentration of 10   M decomposed NOC-18, and ex-
periments were run with fresh NOC-18.
 Determination of cGMP Levels 
 The cGMP levels in SVZ-derived neural stem cell cultures 
were determined after exposure to drugs for 6 or 24 h using a 
cGMP enzyme immunoassay system (Amersham). All experi-
ments were carried out in duplicate and in the presence of zapri-
nast (50   M ), a phosphodiesterase inhibitor, as previously de-
scribed  [27] . Cell lysis and cGMP measurement were performed 
according to the manufacturer’s instructions. The results are ex-
pressed as femtomoles per million cells.
 Detection of Cell Proliferation and Cell Cycle Analysis by Flow 
Cytometry 
 SVZ cell proliferation was assessed by the incorporation of 
5-ethynyl-2  -deoxyuridine (EdU) and detected by flow cytome-
try, using the Click-iT EdU Alexa Fluor 488 Flow Cytometry As-
say Kit. EdU was added to the SVZ cultures 4 h before fixation. 
Fixation was performed with 70% ethanol overnight. Detection of 
EdU incorporation was based on click chemistry, a copper-cata-
lyzed reaction between an azide (conjugated to a fluorophore) and 
an alkyne (EdU). Fixed cells were incubated for 30 min with Alexa 
Fluor 488 azide and copper sulfate. The cells were then incubated 
with RNase and the nuclear dye 7-actinomycin D (7-AAD) for 30 
min. The cells were analyzed for EdU incorporation and nuclear 
staining on a FACScalibur using the Cellquest software (Becton 
Dickinson, San Jose, Calif., USA). Thirty thousand events were 
acquired per experiment. A minimum of 3 independent experi-
ments were analyzed for each condition. The flow cytometer was 
calibrated with fluorescent standard microbeads (CaliBRITE 
Beads, BD Biosciences, San Jose, Calif., USA) for accurate instru-
ment setting.
 Detection of BrdU Incorporation 
 Cell proliferation was also assessed by the incorporation of the 
thymidine analogue BrdU, which is incorporated into the DNA 
of dividing cells during S phase. BrdU (10   M ) was added to the 
cultures 16 h before fixation  [20, 28] . Nuclei that incorporated 
BrdU in this time window were detected by immunofluorescence 
as follows: following 20 min fixation with 4% paraformalde-
hyde/4% sucrose in PBS, the cells were permeabilized with 1% 
Triton X-100 for 5 min, and DNA was denaturated by treatment 
with 1  M HCl for 30 min at 37  °  C. Nonspecific binding was blocked 
with 3% BSA in PBS-T for 1 h, and then BrdU-positive cells were 
labeled with a rat anti-BrdU antibody (1: 50) for 90 min at room 
temperature. The cells were then incubated with a secondary an-
tibody goat anti-rat IgG conjugated with Alexa Fluor 594 (1: 200) 
for 1 h at room temperature. Nuclei were stained with Hoechst 
33342 (1   g/ml) for 3 min. Coverslips were mounted on glass 
slides using DAKO fluorescence mounting medium Dako Cyto-
mation. The cells were visualized in a fluorescence microscope 
(Axioskop 2 Plus, Zeiss, Jena, Germany) and images were ac-
quired with the Axiovision software 4.7. The number of BrdU-
positive nuclei was counted in 7–10 randomly selected fields for 
each coverslip (in a total of approximately 900–1,200 cells per cov-
erslip), and the data were expressed as percentages of the total 
number of living cells. A minimum of 3 independent experiments 
were analyzed for each condition.
 Western Blot Analysis 
 Cells were lysed in 50 m M Tris-HCl, 10 m M EGTA, 1% Triton 
X-100 and 2 m M MgCl 2 , supplemented with 100   M phenylmeth-
ylsufonyl fluoride, 1 m M dithiothreitol, 1   g/ml chymostatin, 
1   g/ml leupeptin, 1   g/ml antiparin, 5   g/ml pepstatin A, 1 m M 
sodium orthovanadate, and 50 m M NaF, pH 7.4, at 4   °   C. Protein 
concentration was determined by the bicinchoninic acid method 
(BCA TM Protein Assay kit, Pierce, Rockford, Ill., USA), and the 
samples were used for Western blot analysis, after adding 6 ! con-
centrated sample buffer (0.5  M Tris, 30% glycerol, 10% sodium 
dodecyl sulfate, 0.6  M dithiothreitol, 0.012% bromophenol blue) 
and heating, for 5 min, at 95   °   C. Equal amounts of protein were 
separated by electrophoresis on sodium dodecyl sulfate-poly-
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acrylamide gels, and transferred electrophoretically to polyvi-
lydene difluoride membranes. These were then blocked for 1 h at 
room temperature in Tris-buffered saline (137 m M NaCl, 20 m M 
Tris-HCl, pH 7.6) containing 0.1% Tween 20 (TBS-T) and 3% BSA. 
Incubations with primary antibodies (rabbit anti-phospho-
ERK1/2 or mouse anti-ERK1/2, 1: 1,000; Cell Signaling, Danvers, 
Mass., USA) in TBS-T 1% BSA were performed overnight at 4   °  C. 
The membranes were subsequently incubated for 1 h at room tem-
perature with alkaline phosphatase-linked secondary antibodies 
(anti-rabbit or anti-mouse IgG, 1: 20,000) in TBS-T 1% BSA. After 
extensive washing in TBS-T with 0.5% BSA, immunoreactive 
bands were visualized on a VersaDoc 3000 Imaging System (Bio-
Rad, Hercules, Calif., USA) following incubation of the mem-
brane with enhanced chemifluorescence reagent for 5 min. The 
results are expressed as the percentage of control of phospho-
ERK/total ERK ratio. 
 Statistical Analysis 
 Data are expressed as means  8 SEM. Statistical significance 
was determined by using two-tailed t tests or one-factor analysis 
of variance (ANOVA) as appropriate, followed by post hoc Bon-
ferroni’s or Dunnet’s tests, as indicated in the figure legends and 
in the text. Differences were considered significant when p  ! 0.05.
 Results 
 Characterization of SVZ Primary Cultures 
 Cells isolated from the SVZ were cultured as described 
previously (see Materials and Methods), and plated on 
poly- L -lysine-coated coverslips for 5 days. At this stage 
the cells were immunoreactive for the transcription fac-
tor Sox-2, essential for the self-renewal of undifferenti-
ated stem cells, and nestin, a neural precursor cell mark-
er. The percentage of double-labeled cells was approxi-
mately 70%, suggesting that the majority of cells remain 
undifferentiated before being used for experiments 
( fig. 1 ). This abundance of undifferentiated SVZ cells is 
similar to that observed in SVZ primary cultures used in 
previous studies investigating the effects of NO on cell 
proliferation by our group  [20] as well as by others  [18, 
29] .
 NO Increases Cell Proliferation via the Guanylyl 
Cyclase-cGMP Pathway 
 To investigate the involvement of cGMP in the prolif-
erative effect of NO, we evaluated the incorporation of 
thymidine analogues (EdU or BrdU) by SVZ cell cultures 
following treatment with a NO donor (NOC-18). We have 
previously shown that treatment with NOC-18 in the 
range of 1–10   M increases proliferation of SVZ cells, but 
whether cGMP is involved in NO-induced neural stem 
cell proliferation has not been addressed. We first inves-
tigated, by flow cytometry, the involvement of cGMP in 
the proliferative effect of NO after 6 or 24 h following 
treatment with NOC-18 (10   M ). Exposure to NOC-18 for 
6 h increased the incorporation of EdU to 133.4  8 5.12% 
of the control (p  ! 0.001) ( fig. 2 a). After 24 h of NOC-18 
treatment we further increased the EdU incorporation to 
165.3  8 10.2% of the control (p  ! 0.001) ( fig. 2 b). In con-
trol conditions (untreated cells) the percentage of EdU-
positive cells (percentage of total living cells) was 2.4  8 
0.7% at 6 h and 2.2  8 0.9% at 24 h.
 The involvement of cGMP in the proliferative effect of 
NOC-18 was evaluated using the guanylyl cyclase inhibi-
tor ODQ. Treatment with ODQ prevented NO-induced 
EdU incorporation at 24 h (p  ! 0.05), compared to SVZ 
cells treated with NOC-18 alone ( fig. 2 b), suggesting that 
cGMP mediates the effect of NO on cell proliferation for 
Sox-2 Nestin Merge
 Fig. 1. Characterization of SVZ stem cell cultures. Representative laser scanning confocal images of SVZ cells 
labeled against Sox-2 (red) and nestin (green) are shown. Nuclei were labeled with Hoechst 33342 (blue). Scale 
bar: 45   m. Colors refer to the online version only. 
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Table 1. D etermination of cGMP levels in neural stem cell cul-
tures following exposure to NOC-18 for 6 or 24 h
Treatment cGMP levels, fmol/106 cells
6 h Control
NOC-18 
NOC-18 + ODQ
ODQ
23.383.6
257.8870.1*
25.283.5+
25.882.1
24 h Control
NOC-18 
NOC-18 + ODQ
ODQ 
NOC-18 + U0126
U0126
52.483.4
266.3816.7**
25.988.7++
25.2811.9
308.1832.7*
46.3819.3
D ata are expressed as means  8 SEM of 2–4 independent ex-
periments. SVZ cells were treated with NOC-18 (10   M) with or 
without ODQ (50   M), or U0126 (1   M). ODQ and U0126 were 
added before and kept throughout exposure to NOC-18.
* p < 0.001 or ** p < 0.01, significantly different from control; 
+ p < 0.001 or ++ p < 0.01, significantly different from NOC-18, 
one-way ANOVA (Bonferroni’s post-test).
the 24-hour period. However, the proliferative effect of 
NOC-18 after 6 h of treatment was not significantly af-
fected by ODQ (p  1 0.05;  fig. 2 a), suggesting that mecha-
nisms other than guanylyl cyclase and cGMP are respon-
sible for the proliferative effect of NO at 6 h of incubation 
with NOC-18. We then investigated whether the mito-
gen-activated kinase ERK1/2 was involved in the initial 
proliferative effect of NO at 6 h. Inhibition of ERK1/2 ac-
tivation by U0126 indeed prevented the increase in EdU-
positive cells stimulated by NOC-18 at both 6 h (p  ! 0.05) 
and 24 h (p  ! 0.001) of treatment ( fig. 2 c, d). 
 We confirmed that ODQ prevented cell proliferation 
at 24 h following treatment with NOC-18 by evaluating 
the incorporation of BrdU by immunocytochemistry and 
microscopy analysis. Treatment with NOC-18 alone for 
24 h increased the number of BrdU-positive cells from 8.5 
 8 0.3% of total cells (control) to 13.4  8 0.5% (p  ! 0.001), 
and ODQ significantly blocked NOC-18-induced prolif-
eration (4.6  8 0.3%, p  ! 0.001) compared to NOC-18 
alone ( fig. 2 e, f).
 Unlike fresh NOC-18, decomposed NOC-18 did not 
stimulate proliferation of SVZ cells for either 6 or 24 h of 
treatment, as evaluated by EdU incorporation and detec-
tion by flow cytometry ( fig. 2 g).
 We also analyzed intracellular cGMP levels in SVZ 
cells ( table  1 ). In control conditions, cGMP levels were 
23.3  8 3.6 fmol cGMP/10 6 cells at 6 h and 52.4  8 3.4 fmol 
cGMP/10 6 cells at 24 h. NOC-18 alone increased cGMP 
levels more than 5-fold for either 6 or 24 h of treatment 
(p  ! 0.001). ODQ completely blocked NOC-18-induced 
cGMP production at both 6 h (p  ! 0.001) and 24 h (p  ! 
0.01) of treatment (25.2  8 3.5 and 25.9  8 8.7 fmol 
cGMP/10 6 cells, respectively) when compared to NOC-18 
alone. We further investigated a possible crosstalk of the 
ERK1/2 pathway with the production of cGMP at 24 h. A 
blockade of MEK1/2 by U0126 had no effect on cGMP 
production (24 h) compared to cultures treated with 
NOC-18 alone (266.3  8 16.7 fmol cGMP/10 6 cells).
 Since NO may induce apoptosis in neural stem cells 
 [30] , cell death was evaluated in the cultures following 
treatment with NOC-18. Flow cytometry analysis of nu-
clei stained with 7-AAD, as described in the Materials and 
Methods section, showed that NOC-18, alone or in com-
bination with ODQ or U0126, did not significantly affect 
cell viability compared to untreated cultures ( table 2 ).
 The cGMP Analogue 8-Br-cGMP Mimics the 
Proliferative Effect of NOC-18 
 Since cGMP appears to mediate the proliferative effect 
of NO at 24 h, we assessed the proliferative effect of a 
 Fig. 2. NO increases cell proliferation via the guanylyl cyclase-
cGMP pathway for longer (24 h) but not for shorter (6 h) periods 
of cell exposure to NO.  Cell proliferation following treatment 
with NOC-18 (10   M ) in the absence or presence of 50   M ODQ 
for 6 h ( a ) or 24 h ( b ), evaluated by the incorporation of EdU and 
assessed by flow cytometry. Data are expressed as means  8 SEM 
of at least 6 independent experiments. One-way ANOVA (Bonfer-
roni’s post-test).  * * *  p  ! 0.001, significantly different from con-
trol;  +++  p  ! 0.001, significantly different from NOC-18. EdU in-
corporation in neural stem cells following exposure to NOC-18 
(10   M ) in the absence or presence of 1   M U0126, a selective 
MEK1 and MEK2 inhibitor, for 6 h ( c ) or 24 h ( d ), as assessed by 
flow cytometry. Data are expressed as means  8 SEM of at least 4 
independent experiments. One-way ANOVA (Bonferroni’s post-
test).  *  p  ! 0.05 or  * * *  p  ! 0.001, significantly different from con-
trol;  +  p  ! 0.05 or  +++  p  ! 0.001, significantly different from NOC-
18.  e Representative images of BrdU (red) incorporation in neural 
stem cells following exposure to NOC-18 (10   M ) for 24 h in the 
absence or presence of a guanylyl cyclase inhibitor, ODQ (50   M ). 
Nuclei are labeled by Hoechst 33342 (blue). Scale bar: 20   m.
 f ODQ completely blocks the increase in the number of BrdU-
positive cells. Data are expressed as means  8 SEM of at least 4 
independent experiments. One-way ANOVA (Bonferroni’s post-
test).  * * *   p  ! 0.001, significantly different from control; 
 +++  p  ! 0.001, significantly different from 10   M NOC-18.  g De-
composed NOC-18 (D-NOC-18) does not stimulate proliferation 
of SVZ-derived neural stem cells, unlike fresh NOC-18. Data are 
expressed as means  8 SEM of at least 4 independent experiments. 
One-way ANOVA (Dunnet’s post-test).  * * *  p  ! 0.001, significant-
ly different from control. Colors refer to the online version only. 
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cGMP analogue, 8-Br-cGMP (20   M ), by flow cytometry. 
We observed a significant increase in EdU incorporation 
following 6 and 24 h of treatment with 8-Br-cGMP to 
123.6  8 6.1% (p  ! 0.001;  fig.  3 a) and 162.7  8 20.1% 
(p  ! 0.01;  fig. 3 b) of the control, respectively, compared to 
untreated cultures. We further confirmed the 24-hour 
observations by evaluating the incorporation of BrdU by 
immunocytochemistry and microscopy analysis. Treat-
ment with 8-Br-cGMP for 24 h significantly increased the 
number of BrdU-positive cells to 12.4  8 0.5% (p  ! 0.01) 
compared to control (7.0  8 0.2%;  fig. 3 c).
 NO-Induced Activation of the Guanylyl Cyclase 
Pathway Is Independent of ERK/MAPK Pathway 
Activation 
 To identify the intracellular pathways that mediate the 
proliferative effect of NO, we investigated whether the 
guanylyl cyclase pathway is involved in the activation of 
the ERK/MAPK pathway. We showed that NOC-18 alone 
stimulates proliferation of SVZ cultures by activating 
ERK1/2  [20] . To evaluate how fast the phosphorylation of 
ERK1/2 occurs following exposure to NOC-18, we ana-
lyzed the phospho-ERK1/2:total ERK1/2 immunoreac-
tivity ratio at several time points after the stimulus (at 5, 
15, 30 and 60 min). The phosphorylation of ERK1/2 tran-
siently increased to 138.1  8 8.4% of the control at 15 min 
Table 2.  Cell viability in neural stem cell cultures following expo-
sure to NOC-18 with or without U0126 or ODQ
Treatment Live cells
6 h Control
10 M NOC-18 
10 M NOC-18 + 1 M U0126
1 M U0126
10 M NOC-18 + 50 M ODQ
50 M ODQ
90.981.4%
90.081.7% (n.s.)
90.281.9% (n.s.)
92.681.2% (n.s.)
90.681.7% (n.s.)
90.081.6% (n.s.)
24 h Control
10 M NOC-18 
10 M NOC-18 + 1 M U0126
1 M U0126
10 M NOC-18 + 50 M ODQ
50 M ODQ
90.681.2%
91.081.4% (n.s.)
90.181.4% (n.s.)
89.881.8% (n.s.)
91.481.1% (n.s.)
90.582.0% (n.s.)
C ell viability was assessed using the nuclear dye 7-AAD, de-
tected by flow cytometry.
Data are expressed as means 8 SEM of at least 3 independent 
experiments.
p > 0.05 (nonsignificant; n.s.), not different from control, one-
way ANOVA (Dunnett’s post-test).
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 Fig. 3. Effect of the cGMP analogue, 8-Br-
cGMP, on cell proliferation in SVZ neuro-
sphere cultures. EdU incorporation in 
neural stem cells following exposure to 20 
  M 8-Br-cGMP for 6 h ( a ) or 24 h ( b ), as 
assessed by flow cytometry. Two-tailed t 
test.  * * *  p  ! 0.001 or  * *  p  ! 0.01, signifi-
cantly different from control. Data are ex-
pressed as means  8 SEM of at least 4 in-
dependent experiments.  c 8-Br-cGMP (20 
  M ) mimics the proliferative effect of NO, 
as determined by BrdU incorporation fol-
lowing 24 h of treatment. Representative 
images of BrdU-positive cells (red) in neu-
ral stem cell cultures after exposure to 20 
  M 8-Br-cGMP, for 24 h, are shown in the 
panels in  c . Nuclei are labeled with Hoechst 
33342 (blue). Scale bar: 20   m. The data 
represent the percentage of BrdU-positive 
cells and are expressed as means  8 SEM 
of at least 3 independent experiments. 
Two-tailed t test.  * * *  p  ! 0.01, significantly 
different from control. Colors refer to the 
online version only.  
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early activation of ERK1/2 by exogenous NO, since 
KT5823, a PKG inhibitor, did not prevent the increased 
phosphorylation of ERK1/2 following exposure to NOC-
18 for 15 min ( fig. 4 c). 
 The cGMP Analogue 8-Br-cGMP Activates the
ERK/MAPK Pathway via PKG 
 Since the cGMP analogue 8-Br-cGMP increased cell 
proliferation at 6 and 24 h in a similar manner to NOC-18, 
after treatment with 10   M NOC-18 (p  ! 0.001;  fig. 4 a). 
ODQ did not prevent the increase in the phosphorylation 
of ERK1/2 triggered by NOC-18 (164.3  8 6.5% over the 
control), suggesting the activation of ERK by NO is an 
event independent of guanylyl cyclase ( fig. 4 b).
 Since cGMP can activate the cGMP-dependent PKG, 
the involvement of PKG in the activation of ERK1/2 fol-
lowing treatment with NOC-18 was also evaluated. We 
observed that PKG does not appear to be involved in the 
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 Fig. 4. NO activates the ERK/MAPK pathway in a cGMP-inde-
pendent manner.  a Time course analysis of the phosphorylation 
of ERK1/2 following exposure to NOC-18 (10   M ). NOC-18 en-
hanced ERK1/2 phosphorylation as early as at 15 min of treat-
ment. Data are expressed as means  8 SEM of at least 4 indepen-
dent experiments. One-way ANOVA (Bonferroni’s post-test). 
 * * *  p  ! 0.001, significantly different from control.  b Western blot 
analysis of the involvement of guanylyl cyclase in the phosphory-
lation of ERK1/2, in lysates of neural stem cell cultures treated 
with NOC-18 for 15 min. No effect of ODQ (50   M ) on ERK1/2 
phosphorylation was observed. Data are expressed as means  8 
SEM of at least 3 independent experiments. One-way ANOVA 
(Bonferroni’s post-test).  * *  p  ! 0.01 and  *  p  ! 0.05, significantly 
different from control.  c No effect of the PKG inhibitor (KT5823; 
1   M ) on the phosphorylation of ERK1/2 stimulated by exposure 
to NOC-18 (10   M ) for 15 min. One-way ANOVA (Bonferroni’s 
post-test).  *  p  ! 0.05, significantly different from control. 
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we also investigated the ability of 8-Br-cGMP to activate 
the ERK pathway. We analyzed the phospho-ERK1/2:
total ERK1/2 immunoreactivity ratio at 5, 15, 30, 60 and 
120 min following treatment with 8-Br-cGMP. There was 
a steady increase in the levels of phosphorylated ERK1/2 
up to 2 h after treatment. At this time point, 20   M 
8-Br-cGMP induced a two-fold increase in phospho-
ERK1/2:total ERK1/2 immunoreactivity ratio (221.1  8 
12.3% of the control), as compared to untreated cultures 
( fig.  5 a). Inhibition of PKG with KT5823 prevented 
ERK1/2 phosphorylation following exposure to 8-Br-
cGMP for 2 h ( fig. 5 b), suggesting that PKG activation by 
8-Br-cGMP is important for activation of ERK1/2 and oc-
curs upstream of ERK1/2 phosphorylation. Likewise, the 
blockade of the ERK pathway by U0126 prevented EdU 
incorporation stimulated by treatment with 8-Br-cGMP 
for 6 h (102.9  8 4.8%, p  ! 0.05;  fig. 5 c) or 24 h (87.0  8 
5.8%, p  ! 0.01;  fig. 5 d).
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 Fig. 5. The cGMP analogue 8-Br-cGMP increases the phosphory-
lation of ERK1/2.  a Time course analysis of the phosphorylation 
of ERK1/2 in lysates of neural stem cell cultures upon treatment 
with 20   M 8-Br-cGMP. Following exposure to 8-Br-cGMP there 
is a time-dependent increase in the phosphorylation of ERK1/2, 
followed for up to 120 min. Data are expressed as means  8 SEM 
of at least 4 independent experiments. One-way ANOVA (Bonfer-
roni’s post-test).  * * *  p  ! 0.001 and  * *  p  ! 0.01, significantly differ-
ent from control.  b KT5823 prevents the phosphorylation of 
ERK1/2 stimulated by treatment with 8-Br-cGMP for 2 h. One-
way ANOVA (Bonferroni’s post-test).  * * *  p  ! 0.001, significantly 
different from control;  +++  p  ! 0.001, significantly different from 
8-Br-cGMP. EdU incorporation in neural stem cells following ex-
posure to 8-Br-cGMP (20   M ) in the absence or presence of 1   M 
U0126, for 6 h ( c ) or 24 h ( d ), as assessed by flow cytometry. Data 
are expressed as means  8 SEM of at least 4 independent experi-
ments. One-way ANOVA (Bonferroni’s post-test).  * * *  p  ! 0.001, 
significantly different from control;  +  p   ! 0.05 or  ++  p  ! 0.01, sig-
nificantly different from 8-Br-cGMP. 
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 PKG Contributes to Late but Not to Early Proliferation 
Induced by NO 
 The involvement of PKG in the proliferative effect of 
NO was studied by flow cytometry by evaluating the in-
corporation of EdU by SVZ cell cultures following treat-
ment with NOC-18 or 8-Br-cGMP. The blockade of PKG 
by KT5823 had no effect on early proliferation (6 h) 
( fig. 6 a), but significantly prevented the EdU incorpora-
tion induced by NOC-18 treatment at 24 h (97.5  8 15.2%, 
p  ! 0.01), compared to cultures treated with NOC-18 
alone (157.3  8 12.4%;  fig. 6 b). Concerning the exposure 
of SVZ cells to the cGMP analogue, the inhibition of 
PKG prevented the proliferation induced by 8-Br-cGMP 
both for 6 h (102.9  8 2.0%, p  ! 0.05;  fig. 6 c) and 24 h 
(83.8  8 8.1%, p  ! 0.05;  fig. 6 d) compared to 8-Br-cGMP 
alone (123.8  8 6.1 and 162.7  8 20.1% for 6 and 24 h,
respectively). We further confirmed by immunocyto-
chemistry the effect of the PKG inhibitor on the incor-
poration of BrdU in cultures treated with NOC-18 
( fig. 7 a) or with 8-Br-cGMP ( fig. 7 b). KT5823 significant-
ly prevented BrdU incorporation following exposure for 
24 h to either NOC-18 (p  ! 0.05) or 8-Br-cGMP (p  ! 
0.01).
 Flow cytometry analysis of nuclei stained with 7-AAD, 
for the treatments described above, showed that KT5823 
alone or in combination with NOC-18 or 8-Br-cGMP did 
not significantly affect the cell viability of SVZ cells com-
pared to untreated cultures ( table 3 ).
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 Fig. 6. Involvement of the cGMP/PKG signaling pathway in the 
proliferation of neural stem cells. Cell proliferation following 
treatment with NOC-18 (10   M ) in the absence or presence of 
1   M KT5823, a selective PKG inhibitor, for 6 h ( a ) or 24 h ( b ), 
evaluated by incorporation of EdU and assessed by flow cytom-
etry. Data are expressed as means  8 SEM of at least 4 independent 
experiments. One-way ANOVA (Bonferroni’s post-test).  * * *  p  ! 
0.001, significantly different from control;  ++  p  ! 0.001, signifi-
cantly different from NOC-18. EdU incorporation in neural stem 
cells following exposure to 8-Br-cGMP (20   M ) in the absence or 
presence of 1   M KT5823, for 6 h ( c ) or 24 h ( d ), as assessed by 
flow cytometry. Data are expressed as means  8 SEM of at least 4 
independent experiments. One-way ANOVA (Bonferroni’s post-
test).  *  p  ! 0.05 or  * * *  p  ! 0.001, significantly different from con-
trol;  +  p  ! 0.05, significantly different from 8-Br-cGMP. 
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 Discussion 
 In this work, we show that cGMP and PKG are in-
volved in the late proliferative effect triggered by NO in 
neural stem cell cultures, since the inhibition of guanylyl 
cyclase or PKG abolishes cell proliferation induced by 
NO. Although cGMP and PKG were not involved in the 
early activation of ERK1/2, they were mandatory for the 
increase in cell proliferation following treatment with the 
NO donor NOC-18 for 24 h. Moreover, the cGMP ana-
logue 8-Br-cGMP also increased neural stem cell prolif-
eration. We also found that the crosstalk between the 
ERK1/2 pathway and the PKG pathway differs when neu-
ral stem cells are treated directly with the NO donor or 
with the cGMP analogue. 
 Our results demonstrate that NO rapidly and tran-
siently activates ERK1/2 in a cGMP-independent man-
ner, since ODQ did not prevent ERK1/2 phosphorylation. 
Also, the blockade of guanylyl cyclase did not prevent the 
early proliferative effect of NOC-18 at 6 h. Furthermore, 
we have previously shown that phosphorylation and acti-
vation of ERK1/2 is essential for the proliferative effect of 
NO, either at the early stages of cell proliferation follow-
ing exposure to NO (as early as 30 min) or for later end-
points (24 h)  [20] . These data strongly suggest that the 
initial proliferation triggered by NO is dependent on the 
activation of the ERK1/2 pathway, does not require acti-
vation of guanylyl cyclase, and is not dependent on cGMP. 
This early proliferative effect is also independent of PKG, 
which does not contribute to either ERK phosphorylation 
or proliferation. Possibly, NO might directly activate 
components of the ERK pathway (upstream of ERK1/2) 
that are sensitive to NO signaling by S-nitrosylation of 
cysteine residues. For instance, p21Ras has a cysteine res-
idue (Cys118) that is sensitive to NO, and when nitrosyl-
ated, p21Ras becomes activated  [31, 32] .
 Long-term exposure (24 h) to NO increased cell pro-
liferation in a cGMP-dependent manner. The blockade of 
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 Fig. 7. The proliferative effect of NO is PKG-dependent.  a Effect 
of the PKG inhibitor (KT5823; 1   M ) on cell proliferation, upon 
exposure to NOC-18 (10   M ), for 24 h. One-way ANOVA (Bonfer-
roni’s post-test).  *  p  ! 0.05, significantly different from control; 
 +  p  ! 0.05, significantly different from NOC-18.  b KT5823 pre-
vents cell proliferation stimulated by treatment with 8-Br-cGMP 
for 24 h. One-way ANOVA (Bonferroni’s post-test).  *  p  ! 0.05, 
significantly different from control;  +  p  ! 0.05, significantly dif-
ferent from 8-Br-cGMP. 
Table 3.  Cell viability in neural stem cell cultures following expo-
sure to NOC-18 or 8-Br-cGMP with or without KT5823
Treatment Live cells
6 h Control
10 M NOC-18 
10 M NOC-18 + 1 M KT5823
20 M 8-Br-cGMP
20 M 8-Br-cGMP + 1 M KT5823
1 M KT5823
89.781.1%
91.081.9% (n.s.)
89.281.1% (n.s.)
93.081.2% (n.s.)
90.281.2% (n.s.)
92.181.3% (n.s.)
24 h Control
10 M NOC-18 
10 M NOC-18 + 1 M KT5823
20 M 8-Br-cGMP
20 M 8-Br-cGMP + 1 M KT5823
1 M KT5823
87.981.9%
91.082.1% (n.s.)
92.182.3% (n.s.)
89.980.8% (n.s.)
90.081.2% (n.s.)
93.581.1% (n.s.)
C ell viability was assessed using the nuclear dye 7-AAD, de-
tected by flow cytometry.
Data are expressed as means 8 SEM of at least 3 independent 
experiments.
p > 0.05 (nonsignificant; n.s.), not different from control, one-
way ANOVA (Dunnett’s post-test).
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 References 
guanylyl cyclase or PKG completely abolished the prolif-
erative effect of NO at 24 h, suggesting that cGMP and 
PKG signaling are essential for the proliferative effect of 
NO. Our data strongly suggest that the proliferative effect 
of NO is biphasic, i.e. an early increase in proliferation is 
dependent on the MAPK pathway and does not rely on 
guanylyl cyclase or PKG, and for later stages cGMP and 
PKG contribute heavily to the proliferation induced by 
NO. It is worth noting that the production of cGMP was 
independent of the MAPK pathway, since U0126 did not 
prevent the increase in cGMP levels observed following a 
24-hour exposure to NOC-18.
 The cGMP analogue 8-Br-cGMP also triggered cell 
proliferation, and our data show that PKG is important 
for this proliferative effect. 8-Br-cGMP also induced ac-
tivation of ERK1/2, which was now sensitive to the inhi-
bition of PKG, suggesting that phosphorylation of ERK1/2 
following 8-Br-cGMP application to neural stem cells re-
lies on a mechanism dependent on PKG. It remains to be 
established whether PKG directly activates ERK by phos-
phorylation. Furthermore, we observed that blocking 
ERK1/2 activation with U0126 prevents proliferation of 
neural stem cells following treatment with 8-Br-cGMP, 
suggesting that the activation of the MAPK pathway is 
responsible for the proliferative effect of the cGMP ana-
logue. PKG is a serine/threonine kinase that is activated 
upon binding of cGMP, and NO-induced elevation of the 
intracellular levels of cGMP has been reported to direct-
ly regulate the activity of PKG  [33–35] . PKG has been im-
plicated in the regulation of gene expression as reviewed 
by Madhusoodanan and Murad  [23] . Some studies sug-
gest that the cGMP/PKG pathway is involved in the acti-
vation of the MAPK pathway, particularly ERK1/2  [36, 
37] , which appears to be the case in our study where neu-
ral stem cells are treated with a cGMP analogue. When 
the neural stem cells are treated with a NO donor, we ob-
served that the initial ERK1/2 activation is independent 
of cGMP-dependent signaling to initiate the early prolif-
erative events triggered by NO. For longer exposures, sig-
naling via guanylyl cyclase and PKG gains relevance for 
the proliferation stimulated by NO.
 The GC-cGMP pathway is the main effector pathway 
of the biological effects of NO as a second messenger. Al-
though this pathway is expected to participate in the sig-
naling events contributing to the proliferative effect of 
NO treatment in neural stem cells, most evidence up to 
now was circumstantial. Regarding the formation of 
newborn cells from stem cells, it was reported that the 
elevation of cGMP levels by PDE5 inhibition promoted 
PKG activation, enhancing the proliferation of mesen-
chymal stem cells  [38] . Other studies correlated the eleva-
tion of cGMP levels with the enhancement of neurogen-
esis  [25, 26, 39] . Understanding how cGMP and its down-
stream target PKG contribute to the proliferative effect of 
NO can help in better targeting these systems to design 
well-grounded therapies for stimulating endogenous 
neurogenesis for brain repair purposes.
 Altogether, we show that NO can activate two inde-
pendent pathways in a biphasic manner that act to in-
crease neural stem cell proliferation, initially the ERK/
MAPK pathway, and for later stages the guanylyl/cGMP/
PKG pathway. Although there is no evidence of crosstalk 
between these two pathways for the early effect of NO, 
this possibility cannot be excluded for NO-induced cell 
proliferation at later stages. While the early proliferation 
of neural stem cells triggered by NO is independent of 
cGMP and PKG, the complete blockade of the prolifera-
tive effect of NO at later stages by inhibition of either gua-
nylyl cyclase, PKG or ERK1/2 suggests a crosstalk be-
tween these different signaling pathways. 
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